Poster sessions form a vital part of scientific meetings. This shot shows the session held at the 30th CSA meeting in Cape Town, South Africa. in April 2024.

Latest Meetings and Conferences

Three major international conferences are underway in May and June 2024: in Abu Dhabi, UAE, and in Trieste, Italy.

The New York University Abu Dhabi/ICGEB Conference on Drug Discovery, Delivery and Therapeutics, held from 6-8 May 2024, has been convened by six professors of the University, among whom Prof. Piergiorgio Percipalle, ICGEB alumnus, Associate Dean for Research and Graduate Programs, Program Head of Biology, and Professor of Biology, NYUAD. With five ICGEB Principal Investigators in attendance, the delegation, headed by Dr. Lawrence Banks, ICGEB Director-General, includes Dr. Natasa Skoko, Biotechnology Development, and Dr. Luca Braga, Functional Cell Biology, from Trieste, Italy, and Dr. Pawan Molhotra, Malaria Biology, and Dr. Dhiraj Kuman, Cellular Immunology from New Delhi, India.

Consult the Meeting Programme: the event representing a great opportunity to increase ICGEB’s footprint in the country.

**

The 19th International Workshop on p53 is a biennial event of great international scientific renown and is being held for the first time in Italy, in Trieste, May 13-16, 2024. This workshop represents a beacon in the field of global oncology research, bringing together leading scientists engaged in the study of the tumor oncosopressor p53, a crucial gene in cancer. Cancer continues to be a leading cause of death globally, with an estimated 10 million deaths in 2020. Among them, an estimated 4.5 million may have developed cancer with mutations in the oncosuppressor TP53. With the participation of international experts from across disciplines, the latest discoveries in this field will be discussed. With the scientific organising committee including Prof. Giannino Del Sal, ICGEB Trieste, University of Trieste, and IFOM-ETS Milan, Italy, Dr. Lawrence Banks, ICGEB Trieste, Dr. Giovanni Blandino, Regina Elena National Cancer Institute, Rome, and Prof. Gerry Melino, University of Rome Tor Vergata, Italy.

**